Amplification-based DNA analysis in the diagnosis of prosthetic joint infection

Bernard Vandercam1, Sabine Jeumont, Olivier Cornu

  • 1Division of Infectious Diseases, St-Luc's University Hospital, Université catholique de Louvain, Brussels, Belgium.

Insights

DNA-based molecular methods significantly improve prosthetic joint infection (PJI) diagnosis compared to traditional cultures. These amplification-based techniques enhance pathogen identification, particularly in patients undergoing revision arthroplasty with prior antibiotic exposure.

Area of Science:

  • Orthopedic Surgery
  • Infectious Diseases
  • Molecular Diagnostics

Background:

  • Prosthetic joint infection (PJI) diagnosis relies on microbiological cultures, which have moderate sensitivity.
  • Enhancing diagnostic accuracy for PJI is crucial for effective treatment and patient outcomes.

Purpose of the Study:

  • To evaluate if amplification-based DNA methods on intraoperative samples improve PJI diagnosis compared to culture alone.
  • To assess the utility of molecular techniques in routine surgical practice for PJI detection.

Main Methods:

  • Revision arthroplasty patients (n=41) with suspected PJI and osteoarthrosis controls (n=28) were included.
  • Polymerase chain reaction (PCR) amplified 16S ribosomal DNA and Staphylococcus-specific femA genes.
  • Amplicon sequencing identified species, and mecA gene amplification detected methicillin resistance.

Main Results:

  • Molecular assays identified causative organisms in 91.2% (31/34) of PJI patients, versus 64.7% (22/34) for cultures.
  • Molecular methods alone identified pathogens in nine PJI patients, including those with recent or ongoing antibiotic treatment.
  • Concordance between molecular and microbiological results was high for bacterial identification and antibiotic resistance.

Conclusions:

  • DNA-based molecular methods effectively complement microbiological cultures for identifying pathogens in intraoperative PJI samples.
  • These molecular techniques are particularly valuable in patients with recent or concomitant antibiotherapy, improving PJI diagnosis.
  • Molecular diagnostics can be integrated into existing sample collection procedures without interference.